Oric Pharmaceuticals, Inc. ORIC Q3 2025 earnings
Reported November 13, 2025 · Before market open
EPS-$0.33Beat by $0.08
EPS estimate-$0.41
Next report
Aug 11, 2026 (In 1 week)EPS estimate-$0.36
Financials
Q3 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Oric Pharmaceuticals, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI

Claude
Questions, answered.
- When did Oric Pharmaceuticals, Inc. report Q3 2025 earnings?
- Oric Pharmaceuticals, Inc. (ORIC) reported Q3 2025 earnings on November 13, 2025 before market open.
- What were Oric Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
- Oric Pharmaceuticals, Inc. reported eps of $-0.33 for Q3 2025.
- Did Oric Pharmaceuticals, Inc. beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-0.41 by $0.08.
- How did Oric Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 32.7% from $-0.49.
- Where can I find Oric Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-280247) and the 10-Q periodic report (0001193125-25-280234) directly on SEC EDGAR. The filing index links above go to sec.gov.